After 127 B2B conversion engagements, the pattern Mayank surfaces in every Stage 3 presentation is consistent: the conversion problem is almost never located where the company thinks it is. The page is almost never the problem.
He leads every CID engagement from Signal Collection through to the Design Intelligence Presentation. Before founding ScaleGrow, he led product and growth at Series A and B fintech and healthtech companies, raised funding, and sat inside the board conversations where a 1% conversion lift is a $2M ARR decision. He has sat on the operator's side of a conversion metric and understands what a 1% lift means at the board level, not just in an analytics dashboard. That context shapes how Stage 3 findings are delivered and why clients act on them.
In Stage 2 of every CID engagement, Shiromani produces the finding that changes the direction of the project. Not a heuristic review. A behavioral diagnosis: identifying precisely where the buying decision breaks down at the cognitive level, naming the mechanism behind the failure, and framing the finding as a testable hypothesis that Stage 4 can be designed to address.
She applies the frameworks from her neuroscience training to commercial conversion problems: cognitive load theory, dual-process thinking, attention hierarchy, trust signal sequencing, and decision friction analysis. She has applied this framework across 127 engagements in fintech, healthtech, and B2B SaaS.
